Keynote Session 4 – Novel Lab Technologies Keynote Session 4 – Novel lab technologies Digital Transformation and Drug Discovery Christopher Langmead, Executive... Read more
Keynote Session 3 – Creating a Connected Ecosystem Moderator’s Introduction Michael Shanler, VP Distinguished Analyst, Gartner Unlocking the Power of the Proteome in... Read more
Keynote Session 2 – Supporting innovation in Biopharma R&D Moderator’s Introduction Michael Shanler, VP Distinguished Analyst, Gartner Collaboration as the key to delivering the... Read more
Keynote Session 1 – Digital Transformation in the Lab of the Future Moderator’s Introduction Greg Moody, R&D IT Business Leader The Digital Transformation Journey – Are we... Read more
Digital Transformation: Where are we going wrong? Exploring the slow pace of adoption of novel technologies within biopharma R&D
From the beta amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s... Read more
LIMS of the Future In LIMS of the Future, we discussed the tools, technologies and infrastructure needed to support a... Read more
Sustainability and the Lab of the Future Leading with sustainability Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma Research Ltd. February... Read more
Will AI revolutionise pharmaceutical R&D? Will AI revolutionise pharmaceutical R&D? Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma Research... Read more
The Connected Lab – Driving Scientific Innovation Why aim for a Connected Lab? Katrina Costa, MA (Oxon), MSc Science Writer, Open Pharma... Read more
